2CUREX.ST
2cureX AB
Price:  
1.77 
SEK
Volume:  
2,112,130.00
Sweden | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

2CUREX.ST WACC - Weighted Average Cost of Capital

The WACC of 2cureX AB (2CUREX.ST) is 5.0%.

The Cost of Equity of 2cureX AB (2CUREX.ST) is 5.55%.
The Cost of Debt of 2cureX AB (2CUREX.ST) is 5.00%.

Range Selected
Cost of equity 4.10% - 7.00% 5.55%
Tax rate 7.50% - 13.40% 10.45%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.4% - 5.6% 5.0%
WACC

2CUREX.ST WACC calculation

Category Low High
Long-term bond rate 2.5% 3.0%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.32 0.57
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.10% 7.00%
Tax rate 7.50% 13.40%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.4% 5.6%
Selected WACC 5.0%

2CUREX.ST's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 2CUREX.ST:

cost_of_equity (5.55%) = risk_free_rate (2.75%) + equity_risk_premium (5.60%) * adjusted_beta (0.32) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.